WBR0813: Difference between revisions

Jump to navigation Jump to search
Newer edit →
VisualWikitext
Rim Halaby (talk | contribs)
CMEUser, Bureaucrats, nocaptcha, Administrators
27,346 edits
Created page with "{{WBRQuestion |QuestionAuthor={{Rim}} |ExamType=USMLE Step 1 |MainCategory=Pharmacology |SubCategory=Renal |MainCategory=Pharmacology |SubCategory=Renal |MainCategory=Pharmaco..."
 
Sergekorjian (talk | contribs)
CMEUser, Bots, Bureaucrats, bureaucrats, editnews, interwiki, nocaptcha, nukepages, oversight, smwadministrator, Administrators, Widget editors
5,932 edits
No edit summary
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Rim}}
|QuestionAuthor={{YD}} (Reviewed by Serge Korjian)
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Pharmacology
|MainCategory=Pharmacology
Line 8: Line 8:
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Renal
|SubCategory=Renal
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|MainCategory=Pharmacology
Line 20: Line 21:
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Renal
|SubCategory=Renal
|Prompt=A 67 year old man presents to the physician's office for high blood pressure. Physical examination is remarkable for elevated blood pressures and faintly audible abdominal bruits bilaterally. The physician orders a Doppler ultrasound and the diagnosis of high-grade bilateral atherosclerotic renal artery stenosis is made. The physician decides to initiate anti-hypertensive therapy. Which of following medications should be avoided in this patient?
|Prompt=A 67-year-old man presents to the physician's office for high blood pressure. Physical examination is remarkable for elevated blood pressures and faintly audible abdominal bruits bilaterally. The physician orders a Doppler ultrasound and the diagnosis of high-grade bilateral atherosclerotic renal artery stenosis is made. The physician decides to initiate anti-hypertensive therapy. Which of following medications should be avoided in this patient?
|Explanation=Angiotensin-converting enzyme inhibitors (ACE-I) are contraindicated in patients with bilateral renal artery stenosis because they might cause acute kidney injury. In high-grade bilateral renal artery stenosis, the glomerular filtration rate (GFR) depends mostly on the action of angiotensin II (ANGII) depletion of extracellular fluid volume.  
|Explanation=Angiotensin-converting enzyme inhibitors (ACEI) are contraindicated in patients with bilateral renal artery stenosis because they might cause acute kidney injury. In high-grade bilateral renal artery stenosis, the glomerular filtration rate (GFR) depends mostly on the action of angiotensin II (ANGII) depletion of extracellular fluid volume. ANGII regulates renal vascular resistance by activation of renin from the juxtaglomerular cells and the sympathetic nervous system to maintain renal blood flow (RBF) and GFR. It is important to remember that ANGII has a preferential vasoconstrictive role on the efferent arteriole (post-glomerulus) than the afferent arteriole (pre-glomerulus); this mechanism is normally advantageous because it maintains GFR when perfusion pressure decreases. The use of ACE-I and losing the capacity of ANGII to maintain GFR in patients whose renal perfusion is highly dependent on the action of ANGII, such as in bilateral renal artery stenosis or advanced renal disease, will lead to reduced GFR and renal impairment. Accordingly, ACE-I are contraindicated in bilateral renal artery stenosis. The same applies to angiotensin receptor blockers (ARBs) that have a similar effect.
 
ANGII may regulate renal vascular resistance by activation of renin from the juxtraglomerular cells and the sympathetic nervous system to maintain renal blood flow (RBF) and GFR. It is important to remember that ANGII has a preferential vasoconstrictive role on the efferent arteriole (post-glomerulus) than the afferent arteriole (pre-glomerulus); this mechanism is normally advantageous because it maintains GFR when perfusion pressure decreases. The use of ACE-I and losing the capacity of ANGII to maintain GFR in patients whose renal perfusion is highly dependent on the action of ANGII, such as in bilateral renal artery stenosis or advanced renal disease, will lead to reduced GFR and renal impairment. Accordingly, ACE-I are contraindicated in bilateral renal artery stenosis.
 
Educational Objective:
ACE- are contraindicated in bilateral renal artery stenosis.
 
Reference:
Schoolwerth AC, Sica DA, Ballermann BJ, et al. Renal considerations in angiotensin converting enzyme inhibitor therapy. A statement for healthcare professionals from the council on the kidney in cardiovascular disease and the council on high blood pressure research of the American Heart Association. Circulation. 2001; 104:1985-1991.
|AnswerA=Furosemide
|AnswerA=Furosemide
|AnswerAExp=Diuretics in general are not contraindicated in bilateral renal artery stenosis.
|AnswerAExp=Diuretics in general are not contraindicated in bilateral renal artery stenosis.
Line 40: Line 33:
|AnswerE=Metoprolol
|AnswerE=Metoprolol
|AnswerEExp=Beta-blockers are not contraindicated in bilateral renal artery stenosis.
|AnswerEExp=Beta-blockers are not contraindicated in bilateral renal artery stenosis.
|EducationalObjectives=ACE inhibitors are contraindicated in bilateral renal artery stenosis.
|References=Schoolwerth AC, Sica DA, Ballermann BJ, et al. Renal considerations in angiotensin converting enzyme inhibitor therapy. A statement for healthcare professionals from the council on the kidney in cardiovascular disease and the council on high blood pressure research of the American Heart Association. Circulation. 2001; 104:1985-1991.
|RightAnswer=B
|RightAnswer=B
|WBRKeyword=ACE, inhibitor, angiotensin, converting, enzyme, contraindication, bilateral, renal, artery, stenosis, hypertension, high, blood, pressure, Doppler, ultrasonography, ultrasound, artery, bruit, arteries
|WBRKeyword=ACE, inhibitor, angiotensin, converting, enzyme, contraindication, bilateral, renal, artery, stenosis, hypertension, high, blood, pressure, Doppler, ultrasonography, ultrasound, artery, bruit, arteries
|Approved=No
|Approved=Yes
}}
}}

Revision as of 21:01, 4 March 2015
Author [[PageAuthor::Yazan Daaboul, M.D. (Reviewed by Serge Korjian)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pharmacology
Sub Category SubCategory::Renal
Prompt [[Prompt::A 67-year-old man presents to the physician's office for high blood pressure. Physical examination is remarkable for elevated blood pressures and faintly audible abdominal bruits bilaterally. The physician orders a Doppler ultrasound and the diagnosis of high-grade bilateral atherosclerotic renal artery stenosis is made. The physician decides to initiate anti-hypertensive therapy. Which of following medications should be avoided in this patient?]]
Answer A AnswerA::Furosemide
Answer A Explanation AnswerAExp::Diuretics in general are not contraindicated in bilateral renal artery stenosis.
Answer B AnswerB::Enalapril
Answer B Explanation AnswerBExp::ACE-inhibitors are contraindicated in bilateral renal artery stenosis.
Answer C AnswerC::Nifedipine
Answer C Explanation AnswerCExp::Calcium channel blockers are not contraindicated in bilateral renal artery stenosis.
Answer D AnswerD::Hydrochlorothiazide
Answer D Explanation AnswerDExp::Diuretics in general are not contraindicated in bilateral renal artery stenosis.
Answer E AnswerE::Metoprolol
Answer E Explanation AnswerEExp::Beta-blockers are not contraindicated in bilateral renal artery stenosis.
Right Answer RightAnswer::B
Explanation [[Explanation::Angiotensin-converting enzyme inhibitors (ACEI) are contraindicated in patients with bilateral renal artery stenosis because they might cause acute kidney injury. In high-grade bilateral renal artery stenosis, the glomerular filtration rate (GFR) depends mostly on the action of angiotensin II (ANGII) depletion of extracellular fluid volume. ANGII regulates renal vascular resistance by activation of renin from the juxtaglomerular cells and the sympathetic nervous system to maintain renal blood flow (RBF) and GFR. It is important to remember that ANGII has a preferential vasoconstrictive role on the efferent arteriole (post-glomerulus) than the afferent arteriole (pre-glomerulus); this mechanism is normally advantageous because it maintains GFR when perfusion pressure decreases. The use of ACE-I and losing the capacity of ANGII to maintain GFR in patients whose renal perfusion is highly dependent on the action of ANGII, such as in bilateral renal artery stenosis or advanced renal disease, will lead to reduced GFR and renal impairment. Accordingly, ACE-I are contraindicated in bilateral renal artery stenosis. The same applies to angiotensin receptor blockers (ARBs) that have a similar effect.

Educational Objective: ACE inhibitors are contraindicated in bilateral renal artery stenosis.
References: Schoolwerth AC, Sica DA, Ballermann BJ, et al. Renal considerations in angiotensin converting enzyme inhibitor therapy. A statement for healthcare professionals from the council on the kidney in cardiovascular disease and the council on high blood pressure research of the American Heart Association. Circulation. 2001; 104:1985-1991.]]

Approved Approved::Yes
Keyword WBRKeyword::ACE, WBRKeyword::inhibitor, WBRKeyword::angiotensin, WBRKeyword::converting, WBRKeyword::enzyme, WBRKeyword::contraindication, WBRKeyword::bilateral, WBRKeyword::renal, WBRKeyword::artery, WBRKeyword::stenosis, WBRKeyword::hypertension, WBRKeyword::high, WBRKeyword::blood, WBRKeyword::pressure, WBRKeyword::Doppler, WBRKeyword::ultrasonography, WBRKeyword::ultrasound, WBRKeyword::artery, WBRKeyword::bruit, WBRKeyword::arteries
Linked Question Linked::
Order in Linked Questions LinkedOrder::
Retrieved from "https://www.wikidoc.org/index.php?title=WBR0813&oldid=1075120"